TITLE: NANOPSYCHIATRY
Updated: Dec 8, 2022
Author: Prof. Dr. Sampoornam. W, MSc(N)., PhD(N)., MSc(C&P)., MSc(Psy)., SEFM, GRN, OWCN, ATHNA, IFNA, Annai JKK Sampoorani Ammal College of Nursing, Komarapalayam, Namakkal India
International Live Conference on Brain Disorders 2022 Volume: 25A01
DOI: 10.5281/zenodo.7392277
Abstract: Nanomedicine is defined as the area using nanotechnology’s concepts for the benefit of human beings’ health and well-being. The use of the nanotechnology in the development of new drugs has had in the last years a very widespread presence in the pharmaceutical industry. Nanomedicine research has expanded greatly in the last decade. However, very little data concerning research and development in psychiatry or mental health has yet been published. The field of nanopsychiatry will emerge along with alternative interventions for depression and gene therapy for depression. ‘Nanopsychiatry’ is a novel term that is used to emphasize the importance of combining psychiatry with nanomedicine.
Nanoparticles are prepared with organic polymers (organic nanoparticles) and/or inorganic elements (inorganic nanoparticles). Application of nanomaterials as drug carriers in psychiatry has potentially numerous advantages, primarily in terms of the increased therapeutic efficiency of the medicament, and reduction of toxicity. Several research efforts have already been focused on the synthesis of antipsychotic and antidepressant nano-based drug delivery systems. Many of these nanoparticle systems have been successfully tested both in in vitro conditions and on animal experimental models.
Nanoparticles, sized approximately between 1 and 100 nanometers, have in some circumstances the ability to pass through blood-brain barrier. Recently, some researchers have suggested that nanoparticles could be used in various psychiatric diseases. Schizophrenia, endogenous depression, bipolar disorder, and essentially, most of the disorders today treated with antipsychotic and/or anti-depressive medications are potential candidates for nanotherapy. Among nanomedicine, nanopsychiatry specifically deals with the potential role of nanotechnology in solving psychiatry diseases problems.
Biography: Dr. Sampoornam. W was born in India. She earned a Bachelor’s degree in nursing from the Tamil Nadu Dr. M.G.R Medical University, Chennai, India, Master’s Degree in psychiatric nursing from the same university. She was awarded PhD in nursing from Saveetha University, Chennai, India. She earned Master’s Degree in Counseling & Psychotherapy from Tamil Nadu Open University. She has also completed MSc Psychology from Alagappa University. Currently she is a professor in Dhanvantri College of Nursing, Namakkal, India. She has 13 years of teaching experience for UG & PG nursing programmes. She has attended 21 conferences, workshops and webinars. She was also resource person in national & international conferences (USA, Germany). Hitherto she has guided 23 dissertations and 4 theses. She has presented distinctive scientific papers and beside organized various conferences and workshops in Malaysia and Dubai. Hitherto, published 81 scientific papers in national and international journals. She presides as an editor in national and international referred journals. She is a recognized PhD Guide under The Tamilnadu Dr. M.G.R. Medical University, Chennai. She earned Young Scientist Award in Nursing from International Multidisciplinary Research Foundation in 2020. She is the member of TNAI, SAS, Global Research Nurses, Organization of Wound Care Nurses, American Travel Health Nurses Association & IFNA- UK and Ireland Chapter.
